DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Ware KE, Hinz TK, Kleczko E. et al.
A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop.
Oncogenesis 2013;
2 (03) e39
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.